CSL Behring L.L.C.

Patent Owner

Watch Compare Add to Portfolio

Stats

Details

Patent Activity in the Last 10 Years

Technologies

Intl Class Technology Matters Rank in Class
 
  
 
A61K PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES 7248
 
  
 
C07K PEPTIDES 4132
 
  
 
B01D SEPARATION 1133

Top Patents (by citation)

Upgrade to the Professional Level to View Top Patents for this Owner. Learn More

Recent Publications

  • No Recent Publications to Display

Recent Patents

Patent # Title Filing Date Issue Date Intl Class
9320783 Methods of treatment using alpha-1-antitrypsin compositionsJul 17, 15Apr 26, 16[A61K, G01N, C07K, B01D]
8722624 Alpha-1-antitrypsin compositions and methods of useFeb 28, 12May 13, 14[A61K]
8124736 Alpha-1-antitrypsin compositionsAug 13, 10Feb 28, 12[A61K]
7777006 Method for purification of alpha-1-antitrypsinDec 31, 02Aug 17, 10[A61K]
6139878 Method for preparing a diafiltered stabilized blood productApr 27, 98Oct 31, 00[A61K]
6063909 Preparation of factor IXAug 03, 93May 16, 00[C07K]
6043215 Preparation of factor IXJun 06, 95Mar 28, 00[C07K]
5847086 Therapeutic fragments of von Willebrand factorJun 07, 95Dec 08, 98[A61K]
5539086 Therapeutic fragments of von Willebrand factorFeb 18, 94Jul 23, 96[A61K, C07K]

Expired/Abandoned/Withdrawn Patents

Patent # Title Status Filing Date Issue/Pub Date Intl Class
2014/0323,405 ALPHA-1-ANTITRYPSIN COMPOSITIONSAbandonedMar 24, 14Oct 30, 14[C07K]
2002/0046,054 Use of blood and plasma donor samples and data in the drug discovery processAbandonedAug 27, 01Apr 18, 02[G05B]
6280729 Preparation of factor IXExpiredMar 13, 00Aug 28, 01[A61K]

Top Inventors for This Owner

Upgrade to the Professional Level to View Top Inventors for this Owner. Learn More

We are sorry but your current selection exceeds the maximum number of comparisons () for this membership level. Upgrade to our Level for up to -1 comparisons!

We are sorry but your current selection exceeds the maximum number of portfolios (0) for this membership level. Upgrade to our Level for up to -1 portfolios!.